ACOG
ALPHA COGNITION (ACOG)
NASDAQ
$6.05-$0.03 (-0.48%)
Price as of Jun 03, 2026 7:02 PM EDT
  • $134.8M
    Market Cap
  • -36.50%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
6.8M
N/A
N/A
N/A
Cost of Revenue
474,006
N/A
N/A
N/A
Gross Profit
6.3M
N/A
0
N/A
Sales and Marketing Expense
29.1M
+29,710.96%
97,535
N/A
Research and Development Expense
-1.9M
-52.33%
-3.9M
N/A
Depreciation and Amortization Expense
58,572
-27.88%
81,220
N/A
Total Operating Expenses
32.9M
+177.23%
11.9M
N/A
Operating Profit
-22.7M
+91.06%
-11.9M
N/A
Interest Income
N/A
N/A
161,664
N/A
Interest Expense
N/A
N/A
-2,952
N/A
Interest Income and Expense and Net
0
-100.00%
158,712
N/A
Total Nonoperating Income and Expense
2.0M
+171.71%
-2.8M
N/A
Income before Taxes
-22.7M
+91.06%
-11.9M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-20.7M
+41.22%
-14.6M
N/A
Net Income from Continuing Operations Applicable to Common
-20.8M
+42.43%
-14.6M
N/A
Basic EPS and Net Income
-1.17
-42.08%
-2.02
N/A
Diluted EPS and Net Income
-1.18
-41.58%
-2.02
N/A
Basic Weighted Average Shares
17.7M
+143.94%
7.2M
N/A
Diluted Weighted Average Shares
17.7M
+143.95%
7.2M
N/A
Balance Sheet
Cash and Cash Equivalents
66.0M
+36.05%
48.5M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
66.0M
+36.05%
48.5M
N/A
Total Current Assets
79.0M
+57.23%
50.3M
N/A
Accumulated Depreciation
N/A
N/A
11,994
N/A
Property and Plant and Equipment and Net
328,540
+1,113.35%
27,077
N/A
Total Long-Term Assets
328,540
+618.69%
45,714
N/A
Total Assets
79.7M
+57.14%
50.7M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
911,463
N/A
Total Current Liabilities
9.1M
+172.48%
3.4M
N/A
Total Long-Term Debt
2.4M
-32.01%
3.6M
N/A
Total Long-Term Liabilities
47,181
-54.10%
102,783
N/A
Total Liabilities
17.2M
+85.47%
9.3M
N/A
Retained Earnings
-97.1M
+27.29%
-76.3M
N/A
Total Stockholders Equity
62.5M
+50.81%
41.5M
N/A
Total Shares Outstanding
21.7M
+35.72%
16.0M
N/A
Cash Flow
Cash from Operating Activities
-20.4M
+162.78%
-7.8M
N/A
Capital Expenditures
293,489
+999.17%
26,701
N/A
Cash from Investing Activities
-293,489
+999.17%
-26,701
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
38.2M
-30.33%
54.9M
N/A
Financials Ratio
Gross Margin
93.02%
N/A
N/A
N/A
Operating Margin
-333.64%
N/A
N/A
N/A
Return on Assets
-31.69%
N/A
N/A
N/A
Return on Equity
-39.75%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
8.65
N/A
N/A
N/A
Cash Ratio
7.23
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow